Literature DB >> 24908223

Perioperative complication and surgical outcome in patients with spine metastases: retrospective 200-case series in a single institute.

Byung Ho Lee1, Jin-Oh Park1, Hak-Sun Kim1, Young-Chang Park1, Hwan-Mo Lee1, Seong-Hwan Moon2.   

Abstract

OBJECTIVE: Metastatic spinal disease requires a multidisciplinary approach with advanced surgical techniques which improve longevity and the quality of life. The purpose of this study is to compare the surgical outcomes and perioperative complications and mortality among en bloc, debulking, and palliative surgeries in patients with spinal metastasis.
METHODS: From 2005 to 2010, 200 patients who underwent surgical treatment for spinal metastases were enrolled retrospectively. Clinical analysis included primary cancer type, survival following the diagnosis of cancer, postoperative survival, Tokuhashi score, postoperative functional status, postoperative complications and mortality depending on the surgery type. Enrolled patients were divided into 3 groups: en bloc excision, debulking curettage, and palliative surgery. Surgical outcomes including perioperative complication and mortality were compared based on the surgery type.
RESULTS: The mean age was 59.9 years (range 21-87). The major types of primary cancer were lung (42 cases), liver (27 cases), and colorectal cancer (27 cases). 62 surgeries (31.0%) were en bloc excisions, 82 (41.0%) were debulking, and 56 (28.0%) were palliative operations. The mean Tokuhashi score was 9.2±3.3 in the en bloc group, 7.2±3.0 in the debulking group and 8.2±2.6 in the palliative group (p=0.001, ANOVA). Mean postoperative survivals were 17.9±22.1 months in the en bloc group, 7.0±11.7 months in the debulking group and 8.5±10.8 months in the palliative group (p=0.022, ANOVA). There were 8 (12.9%) postoperative complications in the en bloc group, 17 (20.7%) in the debulking group, and 8 (14.3%) in the palliative group (p=0.016, chi-square). Three patients (4.8%) in the en bloc group had multiple complications, as did 5 (6.1%) in the debulking group and 2 (3.6%) in the palliative group (p=0.925, chi-square). Among 21 total perioperative deaths, 6 (28.6%) were in the en bloc group, 10 (47.6%) in the debulking group, and 5 (23.8%) in the palliative group (p=0.618, chi-square).
CONCLUSION: Postoperative complications were most common in the debulking group compared to the en bloc and palliative groups, despite the fact that there were no differences in the improvement of neurologic deficits after surgery. Therefore, selecting the proper surgery based on the patients' symptoms and neurologic status is of great significance in the planning stage of the surgery.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Perioperative complication; Spinal metastasis; Surgery

Mesh:

Year:  2014        PMID: 24908223     DOI: 10.1016/j.clineuro.2014.04.025

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  11 in total

Review 1.  Surgical complications of extraspinal tumors in the cervical spine: a report of 110 cases and literature review.

Authors:  WenHua Yang; Liang Jiang; XiaoGuang Liu; Feng Wei; Miao Yu; FengLiang Wu; Lei Dang; Hua Zhou; Hua Zhang; ZhongJun Liu
Journal:  Eur Spine J       Date:  2017-08-17       Impact factor: 3.134

2.  Prediction of skeletal-related events in patients with non-small cell lung cancer.

Authors:  Hisaki Aiba; Tomoki Kimura; Takaya Yamagami; Nobuyuki Watanabe; Hironari Sakurai; Hiroaki Kimura; Shingo Shimozaki; Satoshi Yamada; Takanobu Otsuka
Journal:  Support Care Cancer       Date:  2016-03-15       Impact factor: 3.603

3.  Medium to Long-Term Clinical Outcomes of Spinal Metastasectomy.

Authors:  Satoshi Kato; Satoru Demura; Hideki Murakami; Kazuya Shinmura; Noriaki Yokogawa; Ryohei Annen; Motoya Kobayashi; Yohei Yamada; Satoshi Nagatani; Norio Kawahara; Hiroyuki Tsuchiya
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

4.  Cost-Utility Analysis Compared Between Radiotherapy Alone and Combined Surgery and Radiotherapy for Symptomatic Spinal Metastases in Thailand.

Authors:  Pasawat Taechalertpaisarn; Sirichai Wilartratsami; Pochamana Phisalprapa; Chayanis Kositamongkol; Achiraya Teyateeti; Panya Luksanapruksa
Journal:  Neurospine       Date:  2022-05-12

5.  Preoperative prediction for regaining ambulatory ability in paretic non-ambulatory patients with metastatic spinal cord compression.

Authors:  M Ohashi; T Hirano; K Watanabe; K Katsumi; H Shoji; A Sano; H Tashi; I Takahashi; M Wakasugi; Y Shibuya; N Endo
Journal:  Spinal Cord       Date:  2016-10-18       Impact factor: 2.772

6.  Clinical outcome of vertebral compression fracture after single fraction spine radiosurgery for spinal metastases.

Authors:  Isabelle M Germano; Andrea Carai; Puneet Pawha; Seth Blacksburg; Yeh-Chi Lo; Sheryl Green
Journal:  Clin Exp Metastasis       Date:  2015-11-17       Impact factor: 5.150

7.  Factors Associated with Life Expectancy in Patients with Metastatic Spine Disease from Adenocarcinoma of the Lung.

Authors:  C Rory Goodwin; Mohamed H Khattab; Eric W Sankey; Benjamin D Elder; Thomas A Kosztowski; Rachel Sarabia-Estrada; Ali Bydon; Timothy F Witham; Jean-Paul Wolinsky; Ziya L Gokaslan; Daniel M Sciubba
Journal:  Global Spine J       Date:  2015-06-05

8.  Morphometrics predicts overall survival in patients with multiple myeloma spine metastasis: A retrospective cohort study.

Authors:  Hesham Mostafa Zakaria; Erinma Elibe; Mohamed Macki; Richard Smith; David Boyce-Fappiano; Ian Lee; Brent Griffith; Farzan Siddiqui; Victor Chang
Journal:  Surg Neurol Int       Date:  2018-08-22

Review 9.  Surgical Metastasectomy in the Spine: A Review Article.

Authors:  Satoshi Kato; Satoru Demura; Kazuya Shinmura; Noriaki Yokogawa; Takaki Shimizu; Hideki Murakami; Norio Kawahara; Katsuro Tomita; Hiroyuki Tsuchiya
Journal:  Oncologist       Date:  2021-06-12

10.  Epidemiological Characteristics of 1196 Patients with Spinal Metastases: A Retrospective Study.

Authors:  Feng Wang; Hao Zhang; Li Yang; Xiong-Gang Yang; Hao-Ran Zhang; Ji-Kai Li; Rui-Qi Qiao; Yong-Cheng Hu
Journal:  Orthop Surg       Date:  2019-11-22       Impact factor: 2.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.